Simon M F Triphan
Overview
Explore the profile of Simon M F Triphan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Konietzke P, Weinheimer O, Triphan S, Nauck S, Wuennemann F, Konietzke M, et al.
Eur Radiol
. 2025 Jan;
PMID: 39779513
Objectives: We hypothesized that semiquantitative visual scoring of lung MRI is suitable for GOLD-grade specific characterization of parenchymal and airway disease in COPD and that MRI scores correlate with quantitative...
2.
Stewart N, Higano N, Wucherpfennig L, Triphan S, Simmons A, Smith L, et al.
J Magn Reson Imaging
. 2024 Dec;
PMID: 39639777
Lung MRI is an important tool in the assessment and monitoring of pediatric and neonatal lung disorders. MRI can provide both similar and complementary image contrast to computed tomography for...
3.
Ringwald F, Wucherpfennig L, Hagen N, Mucke J, Kaletta S, Eichinger M, et al.
Front Med (Lausanne)
. 2024 Nov;
11:1401473.
PMID: 39606627
Introduction: Segmentation of lung structures in medical imaging is crucial for the application of automated post-processing steps on lung diseases like cystic fibrosis (CF). Recently, machine learning methods, particularly neural...
4.
Wielputz M, Stahl M, Triphan S, Wucherpfennig L, Leutz-Schmidt P, Gestewitz S, et al.
Ann Am Thorac Soc
. 2024 Sep;
PMID: 39255452
Rationale: The progression of lung changes in cystic fibrosis (CF) from infancy through adolescence remains poorly understood due to limited longitudinal imaging data. Objectives: To assess changes in lung morphology...
5.
Konietzke P, Weinheimer O, Triphan S, Nauck S, Wuennemann F, Konietzke M, et al.
Respiration
. 2024 Aug;
104(2):133-150.
PMID: 39173593
Introduction: The aim of this study was to apply quantitative computed tomography (QCT) for GOLD-grade specific disease characterization and phenotyping of air-trapping, emphysema, and airway abnormalities in patients with chronic...
6.
Zhang K, Triphan S, Wielputz M, Ziener C, Ladd M, Schlemmer H, et al.
Z Med Phys
. 2024 Jul;
35(1):87-97.
PMID: 38960810
Purpose: To apply velocity selective arterial spin labeling (VSASL) combined with a navigator-based (NAV) prospective motion compensation method for a free-breathing liver perfusion measurement without contrast agent. Methods: Sinc-modulated Velocity...
7.
Zhang K, Triphan S, Wielputz M, Ziener C, Ladd M, Schlemmer H, et al.
NMR Biomed
. 2024 May;
37(10):e5173.
PMID: 38783837
Purpose: The purpose of this work is to apply multi-echo spin- and gradient-echo (SAGE) echo-planar imaging (EPI) combined with a navigator-based (NAV) prospective motion compensation method for a quantitative liver...
8.
Triphan S, Konietzke M, Biederer J, Eichinger M, Vogelmeier C, Jorres R, et al.
Front Med (Lausanne)
. 2024 Jan;
10:1254003.
PMID: 38249975
Introduction: Due to hypoxic vasoconstriction, perfusion is interesting in the lungs. Magnetic Resonance Imaging (MRI) perfusion imaging based on Dynamic Contrast Enhancement (DCE) has been demonstrated in patients with Chronic...
9.
Zhang K, Triphan S, Wielputz M, Ziener C, Ladd M, Schlemmer H, et al.
Magn Reson Imaging
. 2023 Nov;
105:75-81.
PMID: 37939972
Purpose: To apply multi-shot high-resolution multi inversion spin and gradient echo (MI-SAGE) acquisition for simultaneous liver T, T and T* mapping. Methods: Inversion prepared spin- and gradient-echo EPI was developed...
10.
Wucherpfennig L, Triphan S, Wege S, Kauczor H, Heussel C, Sommerburg O, et al.
Ann Am Thorac Soc
. 2023 Aug;
20(11):1595-1604.
PMID: 37579262
Magnetic resonance imaging (MRI) detects improvements in mucus plugging and bronchial wall thickening, but not in lung perfusion in patients with cystic fibrosis (CF) treated with elexacaftor/tezacaftor/ivacaftor (ETI). To determine...